Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments

Journal of Lipid Research

Volumn 56, Issue 1, 2015, Pages 81-97

  Zheng, Wenchao ^a   Mast, Natalia ^a   Saadane, Aicha ^a   Pikuleva, Irina A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 hydroxy 3 methyl glutaryl CoA reductase; Age related macular degeneration; Cytochrome P450; Liver X receptor; Posttranslational regulation; RPE65; Sterol regulatory element binding protein; Transcriptional regulation

Indexed keywords

APOLIPOPROTEIN D; CHOLESTEROL; LIVER X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; CIS TRANS ISOMERASE; FLUORINATED HYDROCARBON; IDOL PROTEIN, MOUSE; ORPHAN NUCLEAR RECEPTOR; RETINOID ISOMEROHYDROLASE; SIMVASTATIN; SULFONAMIDE; TO-901317; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOD GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; IDOL GENE; LIPID ANALYSIS; LIPID STORAGE; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; RECEPTOR UPREGULATION; RETINA; RPE65 GENE; TRANSCRIPTION REGULATION; ADVERSE EFFECTS; AGONISTS; ANIMAL; DIET; DRUG EFFECTS; GENETICS; HOMEOSTASIS; METABOLISM; UPREGULATION;

ANIMALS; APOLIPOPROTEINS D; CHOLESTEROL; CIS-TRANS-ISOMERASES; DIET; FEMALE; HOMEOSTASIS; HYDROCARBONS, FLUORINATED; MICE; ORPHAN NUCLEAR RECEPTORS; RETINA; SIMVASTATIN; SULFONAMIDES; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84920514857     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M053439     Document Type: Article

References (81)

1. Brown, M. S., and J. L. Goldstein. 2009. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 50 (Suppl.): S15-S27.
2. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
3. Repa, J. J., and D. J. Mangelsdorf. 2000. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16: 459-481.
4. Yang, C., J. G. McDonald, A. Patel, Y. Zhang, M. Umetani, F. Xu, E. J. Westover, D. F. Covey, D. J. Mangelsdorf, J. C. Cohen, et al. 2006. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J. Biol. Chem. 281: 27816-27826.
5. Spann, N. J., L. X. Garmire, J. G. McDonald, D. S. Myers, S. B. Milne, N. Shibata, D. Reichart, J. N. Fox, I. Shaked, D. Heudobler, et al. 2012. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell. 151:138-52.
6. Wang, N., C. A. Koutz, and R. E. Anderson. 1993. A method for the isolation of retinal pigment epithelial cells from adult rats. Invest. Ophthalmol. Vis. Sci. 34: 101-107.
7. Fliesler, S. J., R. Florman, L. M. Rapp, S. J. Pittler, and R. K. Keller. 1993. In vivo biosynthesis of cholesterol in the rat retina. FEBS Lett. 335: 234-238.
8. Fliesler, S. J., and R. K. Keller. 1995. Metabolism of [3H]farnesol to cholesterol and cholesterogenic intermediates in the living rat eye. Biochem. Biophys. Res. Commun. 210: 695-702.
9. Elner, V. M. 2002. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans. Am. Ophthalmol. Soc. 100: 301-338.
10. Tserentsoodol, N., J. Sztein, M. Campos, N. V. Gordiyenko, R. N. Fariss, J. W. Lee, S. J. Fliesler, and I. R. Rodriguez. 2006. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol. Vis. 12: 1306-1318.
11. Zheng, W., R. E. Reem, S. Omarova, S. Huang, P. L. DiPatre, C. D. Charvet, C. A. Curcio, and I. A. Pikuleva. 2012. Spatial distribution of the pathways of cholesterol homeostasis in human retina. PLoS ONE. 7: e37926.
12. Li, M., C. Jia, K. L. Kazmierkiewicz, A. S. Bowman, L. Tian, Y. Liu, N. A. Gupta, H. V. Gudiseva, S. S. Yee, M. Kim, et al. 2014. Comprehensive analysis of gene expression in human retina and supporting tissues. Hum. Mol. Genet. 23: 4001-4014.
13. Pikuleva, I. A., and C. A. Curcio. 2014. Cholesterol in the retina: the best is yet to come. Prog. Retin. Eye Res. 41: 64-89.
14. Fliesler, S. J., and L. Bretillon. 2010. The ins and outs of cholesterol in the vertebrate retina. J. Lipid Res. 51: 3399-3413.
15. Yang, H., S. Zheng, Y. Qiu, Y. Yang, C. Wang, P. Yang, Q. Li, and B. Lei. 2014. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 55: 2795-2804.
16. Dubrac, S., S. R. Lear, M. Ananthanarayanan, N. Balasubramaniyan, J. Bollineni, S. Shefer, H. Hyogo, D. E. Cohen, P. J. Blanche, R. M. Krauss, et al. 2005. Role of CYP27A in cholesterol and bile acid metabolism. J. Lipid Res. 46: 76-85.
17. Liao, W-L., G-Y. Heo, N. G. Dodder, R. E. Reem, N. Mast, S. Huang, P. L. DiPatre, I. V. Turko, and I. A. Pikuleva. 2011. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. J. Proteome Res. 10: 241-248.
18. Mast, N., R. Reem, I. Bederman, S. Huang, P. L. DiPatre, I. Bjorkhem, and I. A. Pikuleva. 2011. Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. Invest. Ophthalmol. Vis. Sci. 52: 594-603.
19. Wang, M., G. Y. Heo, S. Omarova, I. A. Pikuleva, and I. V. Turko. 2012. Sample prefractionation for mass spectrometry quantification of low-abundance membrane proteins. Anal. Chem. 84: 5186-5191.
20. Omarova, S., C. D. Charvet, R. E. Reem, N. Mast, W. Zheng, S. Huang, N. S. Peachey, and I. A. Pikuleva. 2012. Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis. J. Clin. Invest. 122: 3012-3023.
21. Hamel, C. P., E. Tsilou, B. A. Pfeffer, J. J. Hooks, B. Detrick, and T. M. Redmond. 1993. Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J. Biol. Chem. 268: 15751-15757.
22. Jin, M., S. Li, W. N. Moghrabi, H. Sun, and G. H. Travis. 2005. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell. 122: 449-459.
23. Moiseyev, G., Y. Chen, Y. Takahashi, B. X. Wu, and J. X. Ma. 2005. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc. Natl. Acad. Sci. USA. 102: 12413-12418.
24. Redmond, T. M., E. Poliakov, S. Yu, J. Y. Tsai, Z. Lu, and S. Gentleman. 2005. Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc. Natl. Acad. Sci. USA. 102: 13658-13663.
25. Rosen, H., A. Reshef, N. Maeda, A. Lippoldt, S. Shpizen, L. Triger, G. Eggertsen, I. Bjorkhem, and E. Leitersdorf. 1998. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 273: 14805-14812.
26. Repa, J. J., E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy, and S. D. Turley. 2000. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 275: 39685-39692.
27. Ba˚vner, A., M. Shafaati, M. Hansson, M. Olin, S. Shpitzen, V. Meiner, E. Leitersdorf, and I. Björkhem. 2010. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase. J. Lipid Res. 51: 2722-2730.
28. Kalaany, N. Y., and D. J. Mangelsdorf. 2006. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68: 159-191.
29. Mak, P. A., H. R. Kast-Woelbern, A. M. Anisfeld, and P. A. Edwards. 2002. Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors. J. Lipid Res. 43: 2037-2041.
30. Hoeke, M. O., J. Heegsma, M. Hoekstra, H. Moshage, and K. N. Faber. 2014. Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1. PLoS ONE. 9: e88011.
31. Saadane, A., N. Mast, C. Charvet, S. Omarova, W. Zheng, S. S. Huang, T. S. Kern, N. S. Peachey, and I. A. Pikuleva. 2014. Retinal and non-ocular abnormalities in Cyp27a1 -/- Cyp64a1 -/ - mice with dysfunctional metabolism of cholesterol. Am. J. Pathol. 184: 2403-2419.
32. Mast, N., M. Linger, M. Clark, J. Wiseman, C. D. Stout, and I. A. Pikuleva. 2012. In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine. Mol. Pharmacol. 82: 824-834.
33. Heo, G. Y., W. L. Liao, I. V. Turko, and I. A. Pikuleva. 2012. Features of the retinal environment which affect the activities and product profile of cholesterol-metabolizing cytochromes P450 CYP27A1 and CYP11A1. Arch. Biochem. Biophys. 518: 119-126.
34. Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 21: 2933-2942.
35. Duncan, K. G., K. Hosseini, K. R. Bailey, H. Yang, R. J. Lowe, M. T. Matthes, J. P. Kane, M. M. LaVail, D. M. Schwartz, and J. L. Duncan. 2009. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br. J. Ophthalmol. 93: 1116-1120.
36. Pfrieger, F. W., and N. Ungerer. 2011. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50: 357-371.
37. DeBose-Boyd, R. A. 2008. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18: 609-621.
38. Jo, Y., and R. A. Debose-Boyd. 2010. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit. Rev. Biochem. Mol. Biol. 45: 185-198.
39. Burg, J. S., and P. J. Espenshade. 2011. Regulation of HMG-CoA reductase in mammals and yeast. Prog. Lipid Res. 50: 403-410.
40. Schultz, J. R., H. Tu, A. Luk, J. J. Repa, J. C. Medina, L. Li, S. Schwendner, S. Wang, M. Thoolen, D. J. Mangelsdorf, et al. 2000. Role of LXRs in control of lipogenesis. Genes Dev. 14: 2831-2838.
41. Walczak, R., S. B. Joseph, B. A. Laffitte, A. Castrillo, L. Pei, and P. Tontonoz. 2004. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. J. Biol. Chem. 279: 9905-9911.
42. Jager, R. D., W. F. Mieler, and J. W. Miller. 2008. Age-related macular degeneration. N. Engl. J. Med. 358: 2606-2617.
43. Tang, J., and T. S. Kern. 2011. Inflammation in diabetic retinopathy. Prog. Retin. Eye Res. 30: 343-358.
44. Zelcer, N., C. Hong, R. Boyadjian, and P. Tontonoz. 2009. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 325: 100-104.
45. Hong, C., S. Duit, P. Jalonen, R. Out, L. Scheer, V. Sorrentino, R. Boyadjian, K. W. Rodenburg, E. Foley, L. Korhonen, et al. 2010. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J. Biol. Chem. 285: 19720-19726.
46. Zhang, L., K. Reue, L. G. Fong, S. G. Young, and P. Tontonoz. 2012. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis. Arterioscler. Thromb. Vasc. Biol. 32: 2541-2546.
47. Scotti, E., M. Calamai, C. N. Goulbourne, L. Zhang, C. Hong, R. R. Lin, J. Choi, P. F. Pilch, L. G. Fong, P. Zou, et al. 2013. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor. Mol. Cell. Biol. 33: 1503-1514.
48. Perdomo, G., and H. Henry Dong. 2009. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany NY). 1: 17-27.
49. Chakravarthy, U., T. Y. Wong, A. Fletcher, E. Piault, C. Evans, G. Zlateva, R. Buggage, A. Pleil, and P. Mitchell. 2010. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 10: 31.
50. Björkhem, I., T. Miettinen, E. Reihnér, S. Ewerth, B. Angelin, and K. Einarsson. 1987. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J. Lipid Res. 28: 1137-1143.
51. Kempen, H. J., J. F. Glatz, J. A. Gevers Leuven, H. A. van der Voort, and M. B. Katan. 1988. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J. Lipid Res. 29: 1149-155.
52. Lund, E., L. Sisfontes, E. Reihner, and I. Bjorkhem. 1989. Determination of serum levels of unesterified lathosterol by isotope dilution-mass spectrometry. Scand. J. Clin. Lab. Invest. 49: 165-171.
53. Sierra, S., M. C. Ramos, P. Molina, C. Esteo, J. A. Vazquez, and J. S. Burgos. 2011. Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. J. Alzheimers Dis. 23: 307-318.
54. Evans, B. A., J. E. Evans, S. P. Baker, K. Kane, J. Swearer, D. Hinerfeld, R. Caselli, E. Rogaeva, P. St George-Hyslop, M. Moonis, et al. 2009. Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 27: 519-524.
55. Curcio, C. A., M. Johnson, M. Rudolf, and J. D. Huang. 2011. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 95: 1638-1645.
56. Barathi, V. A., S. W. Yeo, R. H. Guymer, T. Y. Wong, and C. D. Luu. 2014. Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 55: 460-468.
57. Guymer, R. H., P. N. Baird, M. Varsamidis, L. Busija, P. N. Dimitrov, K. Z. Aung, G. A. Makeyeva, A. J. Richardson, L. Lim, and L. D. Robman. 2013. Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration. PLoS ONE. 8: e83759.
58. Liao, J. K., and U. Laufs. 2005. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45: 89-118.
59. Calabrò, P., and E. T. Yeh. 2005. The pleiotropic effects of statins. Curr. Opin. Cardiol. 20: 541-546.
60. Song, B. L., and R. A. DeBose-Boyd. 2004. Ubiquitination of 3-hy-droxy-3-methylglutaryl-CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase. J. Biol. Chem. 279: 28798-28806.
61. Wikvall, K. 1984. Hydroxylations in biosynthesis of bile acids. Isolation of a cytochrome P-450 from rabbit liver mitochondria catalyzing 26-hydroxylation of C27-steroids. J. Biol. Chem. 259: 3800-3804.
62. Sene, A., A. A. Khan, D. Cox, R. E. Nakamura, A. Santeford, B. M. Kim, R. Sidhu, M. D. Onken, J. W. Harbour, S. Hagbi-Levi, et al. 2013. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 17: 549-561.
63. Hazra, S., A. Rasheed, A. Bhatwadekar, X. Wang, L. C. Shaw, M. Patel, S. Caballero, L. Magomedova, N. Solis, Y. Yan, et al. 2012. Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes. Diabetes. 61: 3270-3279.
64. Li, X., V. Yeh, and V. Molteni. 2010. Liver X receptor modulators: a review of recently patented compounds (2007-2009). Expert Opin. Ther. Pat. 20: 535-562.
65. Jakobsson, T., E. Treuter, J. A. Gustafsson, and K. R. Steffensen. 2012. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol. Sci. 33: 394-404.
66. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA. 96: 266-271.
67. Mast, N., Y. Li, M. Linger, M. Clark, J. Wiseman, and I. A. Pikuleva. 2014. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J. Biol. Chem. 289: 3529-3538.
68. Lund, E. G., J. M. Guileyardo, and D. W. Russell. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA. 96: 7238-7243.
69. Bretillon, L., U. Diczfalusy, I. Bjorkhem, M. A. Maire, L. Martine, C. Joffre, N. Acar, A. Bron, and C. Creuzot-Garcher. 2007. Cholesterol- 24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 32: 361-366.
70. Skerra, A. 2000. Lipocalins as a scaffold. Biochim. Biophys. Acta. 1482: 337-350.
71. Eichinger, A., A. Nasreen, H. J. Kim, and A. Skerra. 2007. Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J. Biol. Chem. 282: 31068-31075.
72. Hu, C. Y., W. Y. Ong, R. K. Sundaram, C. Chan, and S. C. Patel. 2001. Immunocytochemical localization of apolipoprotein D in oligodendrocyte precursor-like cells, perivascular cells, and pericytes in the human cerebral cortex. J. Neurocytol. 30: 209-218.
73. Jansen, P. J., D. Lutjohann, K. M. Thelen, K. von Bergmann, F. van Leuven, F. C. Ramaekers, and M. Monique. 2009. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels. J. Alzheimers Dis. 18: 319-329.
74. Amaratunga, A., C. R. Abraham, R. B. Edwards, J. H. Sandell, B. M. Schreiber, and R. E. Fine. 1996. Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J. Biol. Chem. 271: 5628-5632.
75. Kuhrt, H., W. Hartig, D. Grimm, F. Faude, M. Kasper, and A. Reichenbach. 1997. Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J. Hirnforsch. 38: 223-229.
76. Shanmugaratnam, J., E. Berg, L. Kimerer, R. J. Johnson, A. Amaratunga, B. M. Schreiber, and R. E. Fine. 1997. Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Brain Res. Mol. Brain Res. 50: 113-120.
77. Anderson, D. H., S. Ozaki, M. Nealon, J. Neitz, R. F. Mullins, G. S. Hageman, and L. V. Johnson. 2001. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol. 131: 767-781.
78. Tserentsoodol, N., N. V. Gordiyenko, I. Pascual, J. W. Lee, S. J. Fliesler, and I. R. Rodriguez. 2006. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 12: 1319-1333.
79. Kiser, P. D., and K. Palczewski. 2010. Membrane-binding and enzymatic properties of RPE65. Prog. Retin. Eye Res. 29: 428-442.
80. Albert, A. D., and K. Boesze-Battaglia. 2005. The role of cholesterol in rod outer segment membranes. Prog. Lipid Res. 44: 99-124.
81. Park, P. S. 2014. Constitutively active rhodopsin and retinal disease. Adv. Pharmacol. 70: 1-36.